Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Clinical section of Vitrase NDA submitted

Oct. 14, 2002

INS-365, a mucin stimulant, effective in a rabbit model of dry eye syndrome

Oct. 7, 2002

Humanized anti-VEGF antibody fragment proves effective in wet AMD

Oct. 4, 2002

Phase I/II results for INS-37217 in rhegmatogenous retinal detachment

Oct. 4, 2002

Twelve-month data show efficacy of anecortave acetate in wet AMD

Oct. 2, 2002

ISV-401 safe and effective in acute bacterial conjunctivitis

Oct. 1, 2002

New phase III study for anecortave acetate in AMD

Sep. 5, 2002

Compounds for glaucoma and ocular hypertension with improved profile over natural prostaglandins

Sep. 4, 2002

E.U. approval for Visudyne

Sep. 2, 2002

Subanalysis of SnET2 phase III data

Aug. 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...